Financial and social impacts of drug price changes: Evidence from 2017 healthcare reform in Liaoning Province, China

2021 ◽  
Author(s):  
Fulai Gu ◽  
Xiaobing Liu ◽  
Lian Qi ◽  
Xiaowei Xu ◽  
Zheng Zeng
Keyword(s):  
Drug Price ◽  
Healthcare Reform ◽  
Social Impacts ◽  
Liaoning Province ◽  
Price Changes

Drug price changes may hit Canadian pharmacies

2010 ◽  
Vol 596 (1) ◽  
pp. 11-11
Keyword(s):  
Drug Price ◽  
Price Changes

scholarly journals Assessing Drug Price Changes Over 1 Year and their Influence on Budget Impact

2018 ◽  
Vol 21 ◽  
pp. S222 ◽  
Author(s):  
D Mezzio ◽  
D Brown
Keyword(s):  
Drug Price ◽  
Budget Impact ◽  
Price Changes

PP50 How Do Target Population Sizes In Health Technology Assessments Impact Drug Price Changes?

2019 ◽  
Vol 35 (S1) ◽  
pp. 46-46
Author(s):  
Daniel Liden ◽  
Rachel Jao ◽  
Cameron Lockwood ◽  
Floriane Reinaud
Keyword(s):  
Drug Price ◽  
Price Change ◽  
Target Population ◽  
European Medicines Agency ◽  
Future Price ◽  
Price Changes ◽  
Drug Prices ◽  
Population Sizes ◽  
Price Negotiations ◽  
The Relationship

IntroductionThe relationship between heath technology assessment (HTA) recommendations and drug prices has received little attention in the published literature. We consider whether target population sizes estimated as part of positive HTA decisions impact future price changes. We hypothesize that larger target populations may result in larger drug price reductions, as overall budget impact is an important component of price negotiations.MethodsHTA and pricing data were obtained from the Context Matters Market Access Platform (MAP) and IHS Markit's PharmOnline International (POLI) pricing database, respectively. We analyzed 55 HTA decisions from the Gemeinsame Bundesausschuss (G-BA; Germany) and the Haute Autorité de Santé (HAS; France) for oncology products receiving European Medicines Agency approval between 2011 and the end of 2014. Pricing and HTA histories were tracked from the beginning of 2012 until October 2018. Using multiple regression to control for HTA agency, country-specific scores (Improvement in Actual Benefit and Additional Benefit scores), pack size, and initial price, we examined the relationship between a drug's price change in the year following an HTA review and the increase in target population resulting from the HTA decision.ResultsWe found that larger increases in target population were related to larger reductions in drug prices (p = 0.014). The magnitude of the effect size was low.ConclusionsFor the sample evaluated, we found a small but statistically significant association between target population size increases (as estimated by HTA bodies) and price reductions, supporting our hypothesis that target population plays a role in price negotiations. Confidential discounts and managed-access agreements likely account, in part, for the low magnitude of the observed association. Future work on this topic will involve larger samples covering a greater number of HTA agencies to improve the power and generalizability of the analysis.

Drug purchase price volatility in an academic medical center

2021 ◽  
Author(s):  
Armando Cortes ◽  
Megan Park ◽  
Bryan C McCarthy
Keyword(s):  
Drug Price ◽  
Medical Center ◽  
Academic Medical Center ◽  
Time Frame ◽  
Purchase Price ◽  
Price Changes ◽  
Price Increases ◽  
Academic Medical ◽  
Price Trends ◽  
The Impact

Abstract Purpose Inpatient drug purchase price trends at an 811-bed academic medical center are described. Summary Recent highly publicized drug price increases by pharmaceutical manufacturers have generated public interest in regulatory solutions to reduce drug costs. Monitoring drug price changes through internal dashboards has been demonstrated to aid in purchasing decisions to reduce the impact of drug price changes on inpatient pharmacy drug budgets. In this research, University of Chicago Medicine created an internal dashboard to detail specific inpatient drug purchase price trends. Dashboard data input included all medications purchased through the organization’s group purchasing organization over a 25-month time frame. A total of 69,245 drug purchases of 2,432 unique medications and/or dosage strengths were analyzed in the study. Within the 25-month time period, 706 medications (29%) had a net drug purchase price increase, while 898 (37%) had a net drug purchase price decrease. The range of net price percentage changes for medications with price increases was 0.01% to 733.6%; the range for medications with price decreases was 0.01% to 97.5%. Conclusion Relative to previous purchase prices, drug purchase prices decreased or remained the same more often than they increased over a 25-month time frame. However, drug purchase price percentage changes were far greater for medications whose prices increased rather than decreased.

Limit theorems and price changes in financial markets

1998 ◽  
Vol 77 (5) ◽  
pp. 1353-1356
Author(s):  
Rosario N. Mantegna, H. Eugene Stanley
Keyword(s):  
Financial Markets ◽  
Limit Theorems ◽  
Price Changes

Healthcare Reform and Behavioral Health Part 1: A Sea Change

2011 ◽  
Author(s):  
Lynn McIntosh
Keyword(s):  
Behavioral Health ◽  
Healthcare Reform

Healthcare Reform 2010—A Surgeon’s Perspective

2010 ◽  
Vol 8 (2) ◽  
pp. 80 ◽  
Author(s):  
Daniel J Ullyot ◽  
Keyword(s):  
Healthcare Reform

Managing Environmental and Social Impacts of Hydropower in Bhutan

10.1596/24914 ◽  
2016 ◽  
Author(s):  
Keyword(s):  
Social Impacts

The Social Impacts of Seasonal Migration

10.1596/30010 ◽  
2018 ◽  
Author(s):  
Keyword(s):  
Social Impacts ◽  
Seasonal Migration ◽  
The Social
Sign in / Sign up

Export Citation Format

Share Document